Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
26.77
+0.44 (1.67%)
At close: Nov 25, 2025, 4:00 PM EST
26.50
-0.27 (-1.01%)
After-hours: Nov 25, 2025, 7:01 PM EST
Progyny Market Cap
Progyny has a market cap or net worth of $2.31 billion as of November 25, 2025. Its market cap has increased by 54.66% in one year.
Market Cap
2.31B
Enterprise Value
1.99B
1-Year Change
54.66%
Ranking
Category
Stock Price
$26.77
Market Cap Chart
Since October 25, 2019, Progyny's market cap has increased from $1.31B to $2.31B, an increase of 76.19%. That is a compound annual growth rate of 9.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 2.27B | 54.53% |
| Dec 31, 2024 | 1.47B | -58.78% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.45% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |